Journal of Clinical & Experimental OncologyISSN: 2324-9110

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Commentary,  J Clin Exp Onco Vol: 12 Issue: 3

Exploring Osteosarcoma: Mechanisms of Tumor Formation and Impact on Health

Alberto Wenjie*

1 Department of Urology, Medical University of Vienna, Vienna, Austria

*Corresponding Author: Alberto Wenjie,
Department of Urology, Medical University of Vienna, Vienna, Austria

Received date: 23 May, 2023, Manuscript No. JCEOG-23-104764;

Editor assigned date: 25 May, 2023, PreQC No JCEOG-23-104764 (PQ);

Reviewed date: 08 June, 2023, QC No JCEOG-23-104764;

Revised date: 15 June, 2023, Manuscript No. JCEOG-23-104764 (R);

Published date: 22 June, 2023, DOI: 10.4172/2324-9110.1000357.

Citation: Wenjie A (2023) Exploring Osteosarcoma: Mechanisms of Tumor Formation and Impact on Health. J Clin Exp Oncol 12:3.


Osteosarcoma, the most common primary malignant bone tumor, poses significant challenges in pediatric and young adult populations. By understanding the complex molecular and cellular processes underlying osteosarcoma development, one can enhance early detection, treatment strategies, and patient outcomes. Recognizing the far-reaching effects of osteosarcoma on physical, psychological, and social well-being is important for healthcare professionals, and individuals impacted by this aggressive bone cancer. Osteosarcoma arises from abnormal proliferation of mesenchymal cells that form bone tissue. It most commonly affects the long bones, such as the femur, tibia, and humerus. The disease primarily occurs during periods of rapid bone growth, often in adolescents and young adults.

The development of osteosarcoma involves complex genetic and molecular alterations. Several genetic factors and molecular pathways contribute to tumor formation and progression. TP53 gene mutations are frequently observed in osteosarcoma, leading to impaired cell cycle regulation and increased genomic instability. Disruption of the Retinoblastoma Protein (RB1) pathway plays a major role in osteosarcoma development, resulting in uncontrolled cell growth. Alterations in oncogenes, such as Myelo Cytomatosis Oncogene (MYC) and Mesenchymal Epithelial Transition Receptor (MET), and tumor suppressor genes, including Phosphatase and Tensin Homolog (PTEN) and p16, contribute to osteosarcoma initiation and progression. Dysregulation of the Wnt (Wingless-Related Integration Site) or β- catenin signaling pathway is associated with osteosarcoma, promoting tumor growth and metastasis.

Osteosarcoma exerts a significant impact on various aspects of health and well-being. The effects can be categorized into physical, psychological, and social domains. It is commonly presents with bone pain, swelling, and limited range of motion. Fractures or pathologic bone fractures may occur due to weakened bone structure. Treatment modalities, including surgery, chemotherapy, and radiation therapy, can lead to side effects such as fatigue, nausea, and compromised immune function.

A diagnosis of osteosarcoma can have profound psychological effects on patients and their families. Anxiety, fear, depression, and uncertainty are common emotional responses. Coping with treatment, managing long-term effects, and concerns about prognosis can significantly impact mental well-being. Osteosarcoma may disrupt various aspects of social functioning. The demanding treatment regimens and physical limitations can result in reduced participation in school, work, and social activities.

Significant progress has been made in the diagnosis and treatment of osteosarcoma. Imaging techniques, such as X-rays, Computerised Tomography (CT) scans, and Magnetic Resonance Indexing (MRI), aid in accurate staging and monitoring of the disease. Multi-agent chemotherapy protocols combined with surgical resection are the cornerstone of treatment. Advances in limb-salvage surgery and reconstructive techniques have improved functional outcomes for patients. Biopsy plays a key role in confirming the diagnosis of osteosarcoma. It involves obtaining a tissue sample from the tumor site for microscopic examination. Different types of biopsies, such as needle biopsy or surgical biopsy, may be performed depending on the tumor's location and characteristics. Molecular testing, including genetic and molecular profiling, can provide valuable insights into the tumor's biology, prognosis, and potential treatment options. Genetic tests may identify specific mutations or chromosomal abnormalities associated with osteosarcoma.


Osteosarcoma poses significant challenges due to its intricate mechanisms of tumor formation and profound impact on health. Understanding the genetic and molecular underpinnings of osteosarcoma is essential for developing targeted therapies and improving patient outcomes. Moreover, recognizing the diverse effects of osteosarcoma on physical, psychological, and social well-being helps healthcare professionals provide comprehensive care and support to patients and their families. Continued studies, collaborative efforts, and patient-centered approaches are important for further advancing the understanding and management of osteosarcoma.

international publisher, scitechnol, subscription journals, subscription, international, publisher, science

Track Your Manuscript

Awards Nomination

Media Partners